Technology
Health
Medical

Obalon

$1.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-1.90%) Today
-$0.03 (-1.90%) Today

Why Robinhood?

You can buy or sell Obalon and other stocks, options, ETFs, and crypto commission-free!

About

Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. Read More The company was founded in January 2008 and is headquartered in San Diego, CA.

Employees
103
Headquarters
Carlsbad, California
Founded
2008
Market Cap
36.45M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
151.77K
High Today
$1.57
Low Today
$1.50
Open Price
$1.55
Volume
9.99K
52 Week High
$4.41
52 Week Low
$1.46

Collections

Technology
Health
Medical
Therapy
Medical Devices
2016 IPO
US
North America

News

Associated PressMar 14

Obalon Announces Upcoming Conference Presentations

This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. SAN DIEGO, March 14, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon syst...

82
Associated PressFeb 27

Obalon Announces First Commercial Use of Navigation and Touch Products for Obalon Balloon Administration

SAN DIEGO, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ) announces the first commercial use of the Obalon Navigation System™ and Touch™ Inflation Dispenser for balloon administration. The Obalon Navigation System and Touch Inflation Dispenser are intended to improve the reliability and ease of balloon administration, and to reduce the costs and logistics for physicians to adopt the Obalon Balloon System as a non-surgical treatment for their patients with obesity. Dr. Shawn Gar...

25

Earnings

-$0.71
-$0.59
-$0.47
-$0.35
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 9, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.